STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

BMY BRISTOL MYERS SQUIBB COMPANY StockScouter® Report

7

StockScouter® Score

BRISTOL MYERS SQUIBB COMPANY, a large cap growth company in the healthcare sector, is expected to outperform the market over the next six months with slightly less than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The most recent quarterly earnings report higher than analysts’ consensus forecast. Positive
  • The enterprise value-to-sales ratio is lower than the average for comparably-sized companies in the StockScouter universe. Positive

 

Concerns

  • One or more analysts has significantly decreased quarterly earnings estimates for BMY. Negative
  • Short-term relative price momentum exhibits meaningful weakness. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that large cap stocks will be neutral, growth stocks will be in favor, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 40% done.
Progress: 100% done.
Low
High

Core Model Grades

C
B
B
B

Previous Ratings

7
10
7